In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Over-availability of food: Since cats do not need to hunt to eat when they are confined to the house, they sometimes eat just ...

that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...

The Indiana cat, now named Mr. Satchel, is up for adoption on Humane Fort Wayne's website Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE since 2022. Brenton's work ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart) and Eli Lilly's Humalog (insulin lispro) – will be priced at no ...

Six other cats were found alive at the home, the Ingham County Animal Control and Shelter said Kimberlee Speakman is a digital writer at PEOPLE. She has been working at PEOPLE since 2022.

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

Los Angeles county public health officials have issued a new warning to pet owners to stop feeding dogs and cats raw pet food after the H5N1 bird flu virus was found in product samples.

"Dogs are not four-footed people in fur coats," Coren said. The research on domestic cat intelligence is less plentiful, but some studies have probed the cognitive abilities of cats. "We might ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...

It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...